Exotropin Overview

  • Status
  • Private

  • Latest Deal Type
  • Corporate

  • Financing Rounds
  • 1

Exotropin General Information

Description

Developer of advanced cosmeceuticals utilizing engineered exosomes and other proprietary technology intended to accelerate access to the medical aesthetic market and create new topical aesthetic formulations and delivery systems. The company offers cosmeceuticals, small membrane vesicles thereby helping to repair and rejuvenate skin cells, reduce inflammation and oxidative stress, and promote healthy cell signaling for optimal regeneration.

Contact Information

Website
www.exotropin.com
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • PO Box 5298
  • New York, NY 10185
  • United States
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Personal Products
Corporate Office
  • PO Box 5298
  • New York, NY 10185
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Exotropin Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Exotropin‘s full profile, request access.

Request a free trial

Exotropin Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Exotropin‘s full profile, request access.

Request a free trial

Exotropin FAQs

  • Where is Exotropin headquartered?

    Exotropin is headquartered in New York, NY.

  • What industry is Exotropin in?

    Exotropin’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Exotropin a private or public company?

    Exotropin is a Private company.

  • What is Exotropin’s current revenue?

    The current revenue for Exotropin is .

  • Who are Exotropin’s investors?

    Zeo ScientifiX has invested in Exotropin.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process